v3.25.4
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Components of Stock-Based Compensation Expense
The components of stock-based compensation expense were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Stock options$73 $205 $311 $312 
Restricted common stock(1)
98 1,402 47 4,174 
Restricted stock units— 225 14 1,444 
Capitalized costs(2)
(4)(59)(4)(169)
Total stock-based compensation expense$167 $1,773 $368 $5,761 
(1)    See the section entitled “—Jamie Siminoff Restricted Common Stock” below.
(2)    Included in internally-developed software, net on the accompanying Condensed Consolidated Balance Sheets.
Stock-based compensation expense is included in cost of revenue, research and development, sales and marketing and general and administrative on the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cost of revenue$(1)$— $1 $3 
Research and development7 141 53 676 
Sales and marketing(2)30 37 33 
General and administrative163 1,602 277 5,049 
Total stock-based compensation expense$167 $1,773 $368 $5,761 
Schedule of Activity of Stock Options of Employee and Non-Employee
A summary of the status of stock options as of September 30, 2025, and changes during the nine months ended September 30, 2025, is presented below:
Options OutstandingWeighted Average Exercise Price
Weighted Average Remaining Contractual Term(1)
Aggregate Intrinsic Value
Balance at December 31, 202426,436,951 $0.56 
Options granted700,000 $0.16 
Options exercised— $— 
Options forfeited(4,531,832)$0.46 
Options expired(500,402)$0.13 
Balance at September 30, 202522,104,717 $0.58 6$— 
Exercisable at September 30, 202512,013,397 $0.71 2$— 
(1)    Approximately 3.9 million outstanding and exercisable stock options have been excluded from the computation of the weighted average remaining contractual term. The remaining contractual term of such options could not be reasonably estimated as the term end date will not be known until the suspension of the S-8 Registration Statement (as defined below) lapses.
Schedule of Activity of Equity-Based RSUs and Liability-Based RSUs
A summary of RSU activity is presented below:
Number of RSUsWeighted Average Grant Date Fair Value (per unit)
Balance at December 31, 2024375,640 $6.26 
Granted— $— 
Vested and released— $— 
Forfeited— $— 
Balance at September 30, 2025375,640 $6.26